PrairieView Partners’s Merck MRK Stock Holding History

PrairieView Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$14K	Hold	188	–	–	﹤0.01%	263
2025 Q1	$16K	Buy	188 +50	+36%	+$4.67K	﹤0.01%	254
2024 Q4	$13K	Hold	138	–	–	﹤0.01%	269
2024 Q3	$15K	Sell	138 -3,000	-96%	-$356K	﹤0.01%	265
2024 Q2	$388K	Buy	3,138 +3,000	+2,174%	+$386K	0.04%	103
2024 Q1	$19K	Hold	138	–	–	﹤0.01%	248
2023 Q4	$15K	Sell	138 -65	-32%	-$6.75K	﹤0.01%	255
2023 Q3	$20K	Sell	203 -9	-4%	-$970	﹤0.01%	243
2023 Q2	$24K	Sell	212 -16	-7%	-$1.82K	﹤0.01%	255
2023 Q1	$24K	Buy	228 +16	+8%	+$1.73K	﹤0.01%	239
2022 Q4	$23K	Sell	212 -45	-18%	-$4.6K	﹤0.01%	251
2022 Q3	$22K	Buy	257 +10	+4%	+$893	﹤0.01%	242
2022 Q2	$23K	Buy	247 +100	+68%	+$8.87K	﹤0.01%	257
2022 Q1	$12K	Buy	147 +9	+7%	+$710	﹤0.01%	316
2021 Q4	$11K	Hold	138	–	–	﹤0.01%	317
2021 Q3	$10K	Hold	138	–	–	﹤0.01%	273
2021 Q2	$11K	Sell	138 -7	-5%	-$521	﹤0.01%	267
2021 Q1	$11K	Hold	145	–	–	﹤0.01%	267
2020 Q4	$11K	Sell	145 -104	-42%	-$7.95K	﹤0.01%	243
2020 Q3	$20K	Hold	249	–	–	﹤0.01%	195
2020 Q2	$18K	Hold	249	–	–	﹤0.01%	200
2020 Q1	$18K	Buy	+249	New	+$19.6K	﹤0.01%	188

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PrairieView Partners's MRK Position: Q2 2025 in Review

PrairieView Partners held its Merck (MRK) position steady in Q2 2025 at 188 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #263.

PrairieView Partners first reported a position in MRK in Q1 2020 and has held it in 22 quarters since. The position peaked at $388K in Q2 2024. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

PrairieView Partners held 188 shares of Merck worth $14K as of Q2 2025.
PrairieView Partners left its Merck share count unchanged in Q2 2025.
Merck made up ﹤0.01% of PrairieView Partners's portfolio in Q2 2025, its #263 holding.
PrairieView Partners first reported a position in Merck in Q1 2020 and has held it in 22 quarters since.
PrairieView Partners's Merck position peaked at $388K in Q2 2024.
3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on PrairieView Partners's 13F filing for Q2 2025, filed 25 Jul 2025.